Mowery & Schoenfeld Wealth Management, LLC
Position in ABT — Abbott Laboratories
CIK 2019946
LINCOLNSHIRE, IL
Position in ABT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$51,903
-$6,824 QoQ
Shares Held
572
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,784
of 2,959 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Mowery & Schoenfeld Wealth Management, LLC holds $275,708 across 7 Medical Devices names. ABT ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
2,320 | $99,017 | |
| 2 | SYK |
Stryker Corp
|
215 | $67,690 | |
| 3 | ABT |
Abbott Laboratories
This page
|
572 | $51,903 | |
| 4 | MOBI |
Mobia Medical, Inc.
|
3,250 | $43,550 | |
| 5 | STE |
STERIS plc
|
23 | $4,843 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
71 | $4,544 | |
| 7 | EW |
Edwards Lifesciences Corp
|
46 | $4,161 |
All Filings in ABT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,903 | 572 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $58,727 | 572 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $92,338 | 737 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $33,351 | 249 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $38,490 | 283 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $56,243 | 424 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $31,897 | 282 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $148,555 | 1,303 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $135,394 | 1,303 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $148,098 | 1,303 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,871 | 17 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||